Having recently obtained both FDA clearance and CE Mark, BIOTRONIK is bringing to market its Ilesto 7 cardioverter-defibrillator/cardiac resynchronization therapy defibrillator (ICD/CRT-D) devices.
They feature Home Monitoring to allow cardiologists to remotely view patient status and help detect heart conditions that may otherwise be missed during infrequent office visits, and have a working life of up to 11.5 years for the single chamber ICD model.
From BIOTRONIK:
With its new Ilesto 7 Series and existing Lumax 740 ICD/CRT-D series, released in the European market in April 2012, BIOTRONIK offers the world’s only two ICD/CRT-D series approved for MR scanning.
Due to its small size, the Ilesto 7 Series and the new DF4 connector system simplifies and shortens the implantation procedure, is more comfortable for the patient, and also leads to better cosmetic results.
Patients also benefit from secure remote monitoring via BIOTRONIK Home Monitoring®, a unique feature that offers both patients and physicians the ultimate convenience: it does not require any patient interaction. BIOTRONIK Home Monitoring® is the first and only wireless remote system with both FDA and CE approval for early detection of clinically relevant events and reduction of in-office follow-ups.
Flashbacks: BIOTRONIK’s Ilesto 7 Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy Defibrillators Cleared in EU; BIOTRONIK Ilesto 7 ICD/CRT-Ds with Home Monitoring Cleared in U.S.
